INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845P958. A total of 4 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,269,990 | +412.6% | 68,500 | +205.8% | 0.00% | – |
| Q2 2023 | $247,744 | -61.2% | 22,400 | -52.9% | 0.00% | – |
| Q1 2023 | $639,268 | +74.0% | 47,600 | +60.3% | 0.00% | – |
| Q4 2022 | $367,389 | -32.0% | 29,700 | -23.3% | 0.00% | – |
| Q3 2022 | $540,000 | -10.4% | 38,700 | -11.4% | 0.00% | – |
| Q2 2022 | $603,000 | – | 43,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 11,500 | $187,000 | 0.00% |
| SIMPLEX TRADING, LLC | 142,300 | $2,315,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 136,300 | $2,218,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |